Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.

Abstract:

:Current standard of care for patients with pediatric acute lymphoblastic leukemia (ALL) is mainly effective, with high remission rates after treatment. However, the genetic perturbations that give rise to this disease remain largely undefined, limiting the ability to address resistant tumors or develop less toxic targeted therapies. Here, we report the use of next-generation sequencing to interrogate the genetic and pathogenic mechanisms of 240 pediatric ALL cases with their matched remission samples. Commonly mutated genes fell into several categories, including RAS/receptor tyrosine kinases, epigenetic regulators, transcription factors involved in lineage commitment, and the p53/cell-cycle pathway. Unique recurrent mutational hotspots were observed in epigenetic regulators CREBBP (R1446C/H), WHSC1 (E1099K), and the tyrosine kinase FLT3 (K663R, N676K). The mutant WHSC1 was established as a gain-of-function oncogene, while the epigenetic regulator ARID1A and transcription factor CTCF were functionally identified as potential tumor suppressors. Analysis of 28 diagnosis/relapse trio patients plus 10 relapse cases revealed four evolutionary paths and uncovered the ordering of acquisition of mutations in these patients. This study provides a detailed mutational portrait of pediatric ALL and gives insights into the molecular pathogenesis of this disease. Cancer Res; 77(2); 390-400. ©2016 AACR.

journal_name

Cancer Res

journal_title

Cancer research

authors

Ding LW,Sun QY,Tan KT,Chien W,Mayakonda A,Yeoh AEJ,Kawamata N,Nagata Y,Xiao JF,Loh XY,Lin DC,Garg M,Jiang YY,Xu L,Lim SL,Liu LZ,Madan V,Sanada M,Fernández LT,Hema Preethi SS,Lill M,Kantarjian HM,Kornblau SM,

doi

10.1158/0008-5472.CAN-16-1303

subject

Has Abstract

pub_date

2017-01-15 00:00:00

pages

390-400

issue

2

eissn

0008-5472

issn

1538-7445

journal_volume

77

pub_type

杂志文章
  • Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway.

    abstract::Cell adhesion and spreading is a crucial step in the metastatic cascade of cancer cells, and interruption of this step is considered to be a logical strategy for prevention and treatment of tumor metastasis. Emodin is the major active component of the rhizome of Rheum palmatum L., with known anticancer activities. Her...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0077

    authors: Huang Q,Shen HM,Shui G,Wenk MR,Ong CN

    更新日期:2006-06-01 00:00:00

  • Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.

    abstract::The role of oxygen free radicals in the toxicity and antitumor effect of tumor necrosis factor was investigated in vivo. Treatment of non-tumor-bearing mice and mice bearing methylcholanthrene-induced sarcomas with bovine CuZn superoxide dismutase or recombinant human CuZn superoxide dismutase afforded significant pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hauser GJ,McIntosh JK,Travis WD,Rosenberg SA

    更新日期:1990-06-15 00:00:00

  • Inhibition of cyclophosphamide and mitomycin C-induced sister chromatid exchanges in mice by vitamin C.

    abstract::Ascorbic acid (vitamin C) is known to act as an antimutagen and anticarcinogen in several test systems. However, there is no report of its effect on carcinogen-induced chromosomal damage in vivo in animals. The present study was performed to determine whether or not ascorbic acid affects sister chromatid exchanges (SC...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Krishna G,Nath J,Ong T

    更新日期:1986-06-01 00:00:00

  • Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.

    abstract::Non-small cell lung cancer (NSCLC) cells with somatic mutations in K-ras recruit to the tumor a variety of cell types (hereafter collectively termed "stromal cells") that can promote or inhibit tumorigenesis by mechanisms that have not been fully elucidated. Here, we postulated that stromal cells in the tumor microenv...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1529

    authors: Zhong L,Roybal J,Chaerkady R,Zhang W,Choi K,Alvarez CA,Tran H,Creighton CJ,Yan S,Strieter RM,Pandey A,Kurie JM

    更新日期:2008-09-01 00:00:00

  • Effect of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats.

    abstract::In this study of the role of microfloral beta-glucuronidase in colonic carcinogenesis, the effect of beta-glucuronidase inhibitor was evaluated. Starting at 5 weeks of age, male Donryu rats were fed either a semisynthetic diet or the same diet containing 0.1% beta-glucuronidase inhibitor as N-cyclohexyl-5-O-acetyl-2,4...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takada H,Hirooka T,Hiramatsu Y,Yamamoto M

    更新日期:1982-01-01 00:00:00

  • Quantitative tumor cytochemistry--G.H.A. Clowes Memorial Lecture.

    abstract::Quantitative optical cytochemistry permits the determination of many different parameters in whole cells or parts of cells. Total amounts of DNA, RNA, and protein and/or the amounts of these substances in nucleus or nucleolus are examples. Techniques in this field have contributed considerably to the development of ou...

    journal_title:Cancer research

    pub_type: 历史文章,杂志文章

    doi:

    authors: Caspersson TO

    更新日期:1979-07-01 00:00:00

  • Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer.

    abstract::The ErbB2 receptor tyrosine kinase is overexpressed in approximately 25% of breast tumors and contributes to poor patient prognosis and therapeutic resistance. Here, we examine the role of the recently discovered ErbB negative regulator LRIG1 in ErbB2(+) breast cancer. We observe that LRIG1 protein levels are signific...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6316

    authors: Miller JK,Shattuck DL,Ingalla EQ,Yen L,Borowsky AD,Young LJ,Cardiff RD,Carraway KL 3rd,Sweeney C

    更新日期:2008-10-15 00:00:00

  • Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitor.

    abstract::ERBB3/HER3 expression and signaling are upregulated in mutant BRAF melanoma as an adaptive, prosurvival response to FDA-approved RAF inhibitors. Because compensatory ERBB3 signaling counteracts the effects of RAF inhibitors, cotargeting ERBB3 may increase the efficacy of RAF inhibitors in mutant BRAF models of melanom...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0464

    authors: Kugel CH 3rd,Hartsough EJ,Davies MA,Setiady YY,Aplin AE

    更新日期:2014-08-01 00:00:00

  • Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.

    abstract::The bispecific murine monoclonal antibody (MAb) 1A10 has specificity for the human transferrin receptor (TfR) and the human tumor-associated antigen gp40. This antibody, therefore, functions as an "antigen fork" by binding to two distinct antigens on the same malignant cell. Highly purified 1A10 inhibits the growth of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Amoroso AR,Clark JI,Litwin S,Hsieh-Ma S,Shi T,Alpaugh RK,Adams GP,Wolf EJ,Ring DB,Weiner LM

    更新日期:1996-01-01 00:00:00

  • Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.

    abstract::We have carried out a clinical trial in which patients with relapsed leukemia were treated with thymidine (dThd) prior to and concomitantly with the administration of 1-beta-D-arabinofuranosylcytosine (ara-C) in an effort to kinetically and biochemically modulate the leukemic cells with two objectives: (a) to increase...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Blumenreich MS,Chou TC,Andreeff M,Vale K,Clarkson BD,Young CW

    更新日期:1984-02-01 00:00:00

  • Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.

    abstract::The identification of proteins that are preferentially expressed on the membrane of metastatic tumor cells is of fundamental importance in cancer research. Here, we report the systematic comparison of the membrane proteome of two closely related murine teratocarcinoma cell lines (F9B9 and F9DR), of which only one (F9D...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0999

    authors: Roesli C,Borgia B,Schliemann C,Gunthert M,Wunderli-Allenspach H,Giavazzi R,Neri D

    更新日期:2009-07-01 00:00:00

  • Detection and biochemical characterization of antigens in human leukemic sera that cross-react with primate C-type viral proteins (Mr 30,000).

    abstract::Antigens have been detected in 35 to 40% of sera from patients with leukemia that cross-react with the Mr 30,000 core proteins (p30) of baboon endogenous virus (BaEV) and/or of simian sarcoma-simian sarcoma-associated virus (SiSV) in a solid-phase enzyme immunoassay using anti-SiSV p30 and anti-BaEV p30 antisera. Thes...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hehlmann R,Schetters H,Erfle V,Leib-Mösch C

    更新日期:1983-01-01 00:00:00

  • Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.

    abstract::The possibility of decreasing the gastrointestinal (GI) toxic effects of 5-fluorouracil (5-FU) on the digestive tract such as its injury of cells and induction of diarrhea, without reducing its antitumor activity, was investigated in rats. Oxonic acid was found to inhibit the phosphorylation of 5-FU to 5-fluorouridine...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shirasaka T,Shimamoto Y,Fukushima M

    更新日期:1993-09-01 00:00:00

  • Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.

    abstract::CPT-11 [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin ] is a prodrug that is converted to the active metabolite SN-38 by carboxylesterases. In its active form, the drug inhibits topoisomerase I, causes DNA damage, and induces apoptosis. Data in this study show metabolism of CPT-11 to SN-38 (7-ethyl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Danks MK,Morton CL,Pawlik CA,Potter PM

    更新日期:1998-01-01 00:00:00

  • Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.

    abstract::Loss of chromosome 10q is a frequently observed genetic defect in prostate cancer. Recently, the PTEN/MMAC1 tumor suppressor gene was identified and mapped to chromosome 10q23.3. We studied PTEN structure and expression in 4 in vitro cell lines and 11 in vivo xenografts derived from six primary and nine metastatic hum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vlietstra RJ,van Alewijk DC,Hermans KG,van Steenbrugge GJ,Trapman J

    更新日期:1998-07-01 00:00:00

  • Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2.

    abstract::Culture of human peripheral blood leukocytes with interleukin 2 (IL-2) stimulates their differentiation into lymphokine-activated killer (LAK) cells, with a broad range of cytotoxicity against fresh tumor cells and tumor cell lines (Grimm et al., J. Exp. Med., 155: 1823-1841, 1982). We chose to utilize a molecular app...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kovacs EJ,Beckner SK,Longo DL,Varesio L,Young HA

    更新日期:1989-02-15 00:00:00

  • Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma.

    abstract::Indirect immunofluorescence staining with a large battery of monoclonal antibodies of primary and autologous metastatic lesions removed from seven patients with melanoma has detected heterogeneity in the expression of various types of melanoma-associated antigens (MAAs), of distinct determinants of the high molecular ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Natali P,Bigotti A,Cavaliere R,Liao SK,Taniguchi M,Matsui M,Ferrone S

    更新日期:1985-06-01 00:00:00

  • APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.

    abstract::The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like APOBEC3A and APOBEC3B have emerged as key mutation drivers in cancer. Here, we show that APOBEC3A and APOBEC3B activities impose a unique type of replication stress by inducing abasic sites at replication forks. In contrast to cells under other types ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-3389

    authors: Buisson R,Lawrence MS,Benes CH,Zou L

    更新日期:2017-09-01 00:00:00

  • From chronic feed-induced intestinal inflammation to adenocarcinoma with metastases in salmonid fish.

    abstract::Neoplasms in fish normally show poor abilities for metastasis, and there are no reports on intestinal cancer with metastasis to other organs. In aquaculture production, carnivorous salmonids in Northern Europe receive commercial feeds with plant ingredients. Such contents have been shown to cause chronic intestinal in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4877

    authors: Dale OB,Tørud B,Kvellestad A,Koppang HS,Koppang EO

    更新日期:2009-05-15 00:00:00

  • Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.

    abstract::Bropirimine (ABPP), a pyrimidinone, is currently under clinical trial for its antitumor potential. Bropirimine alone was marginally active against some experimental tumors such as B16 melanoma but was ineffective against others such as P388 or L1210 leukemia. However, it produced statistically significant synergistic ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Li LH,DeKoning TF,Wallace TL

    更新日期:1987-11-15 00:00:00

  • Immunological characterization and clinical implication of cobalamin binding protein in human gastric cancer.

    abstract::Cobalamin (vitamin B12) binding protein was purified from gastric cancer extracts and from serum-free culture medium of cancer cell line KATOH-III. The molecular weight, determined by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, was 70,000 and the pI was 2.8 to 3.2. From biochemic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wakatsuki Y,Inada M,Kudo H,Oshio G,Masuda T,Miyake T,Kita T

    更新日期:1989-06-01 00:00:00

  • Progesterone-binding cyst protein in human breast tumor cytosol.

    abstract::Breast tumor cytosol has been analyzed for the presence of a progesterone-binding protein (PBCP), commonly present in benign breast cysts in huge concentrations. In 377 primary carcinoma investigated PBCP was present in measurable quantities in 60.7% using "rocket" immunoelectrophoresis. Concentrations of PBCP ranged ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lea OA,Kvinnsland S,Thorsen T

    更新日期:1987-12-01 00:00:00

  • Antiapoptotic role of endogenous nitric oxide in human melanoma cells.

    abstract::The role of endogenous NO on cell survival was investigated in human melanoma cells and melanocytes. Inducible NO synthase (iNOS) was always expressed in a panel of melanoma cell lines from metastatic lesions and in normal adult melanocytes. iNOS was also detected by immunohistochemistry in melanoma cells from metasta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Salvucci O,Carsana M,Bersani I,Tragni G,Anichini A

    更新日期:2001-01-01 00:00:00

  • Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

    abstract::Brca2 is an important tumor suppressor associated with susceptibility to breast cancer. Although increasing evidence indicates that the primary function of Brca2 is to facilitate the repair of DNA damage via the homologous recombination pathway, how Brca2 prevents breast cancer is largely unknown. To study the role of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-2270

    authors: Cheung AM,Elia A,Tsao MS,Done S,Wagner KU,Hennighausen L,Hakem R,Mak TW

    更新日期:2004-03-15 00:00:00

  • Implementation of micromethods to resolve problems of human breast tumor heterogeneity in analysis of cyclic 3':5'-nucleotide phosphodiesterase.

    abstract::Individual human infiltrating ductal carcinomas and fibroadenomas were sectioned frozen to yield an alternating sequence of stained and lyophilized material. Stained preparations were used as references permitting microdissection of regions of tumor involvement in the corresponding dried sections. Tissues quantities o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Larner EH,Rutherford CL

    更新日期:1982-05-01 00:00:00

  • MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

    abstract::Activation of c-MYC is an oncogenic hallmark of many cancers, including liver cancer, and is associated with a variety of adverse prognostic characteristics. Despite a causative role during malignant transformation and progression in hepatocarcinogenesis, consequences of c-MYC activation for the biology of hepatic can...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0527

    authors: Akita H,Marquardt JU,Durkin ME,Kitade M,Seo D,Conner EA,Andersen JB,Factor VM,Thorgeirsson SS

    更新日期:2014-10-15 00:00:00

  • TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

    abstract::Although common in hematologic and mesenchymal malignancies, recurrent gene fusions have not been well characterized in epithelial carcinomas. Recently, using a novel bioinformatic approach, we identified recurrent gene fusions between TMPRSS2 and the ETS family members ERG or ETV1 in the majority of prostate cancers....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0168

    authors: Tomlins SA,Mehra R,Rhodes DR,Smith LR,Roulston D,Helgeson BE,Cao X,Wei JT,Rubin MA,Shah RB,Chinnaiyan AM

    更新日期:2006-04-01 00:00:00

  • β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q).

    abstract::Deletion of the chromosome 5q [del(5q)] is one of the most common cytogenetic abnormalities observed in patients with de novo myelodysplastic syndromes (MDS) and therapy-related MDS or acute myeloid leukemia (t-MDS/tAML). Emerging evidence indicates that activation of the Wnt/β-catenin pathway contributes to the devel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0202

    authors: Li L,Sheng Y,Li W,Hu C,Mittal N,Tohyama K,Seba A,Zhao YY,Ozer H,Zhu T,Qian Z

    更新日期:2017-08-01 00:00:00

  • Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.

    abstract::Osimertinib, a mutant-specific third-generation EGFR tyrosine kinase inhibitor, is emerging as the preferred first-line therapy for EGFR-mutant lung cancer, yet resistance inevitably develops in patients. We modeled acquired resistance to osimertinib in transgenic mouse models of EGFRL858R -induced lung adenocarcinoma...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-3819

    authors: Starrett JH,Guernet AA,Cuomo ME,Poels KE,van Alderwerelt van Rosenburgh IK,Nagelberg A,Farnsworth D,Price KS,Khan H,Ashtekar KD,Gaefele M,Ayeni D,Stewart TF,Kuhlmann A,Kaech SM,Unni AM,Homer R,Lockwood WW,Michor F,G

    更新日期:2020-05-15 00:00:00

  • Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA.

    abstract::Glucocorticoids are widely used for the treatment of multiple myeloma. To investigate the direct actions of glucocorticoids on myeloma cells, we have used three cell lines of human multiple myeloma, OPM-1, OPM-2, and RPMI 8226. When growth curves of these cells were examined, OPM-1 cells were resistant, while OPM-2 we...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gomi M,Moriwaki K,Katagiri S,Kurata Y,Thompson EB

    更新日期:1990-03-15 00:00:00